Federal

Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations [PDF]

Centers for Disease Control (CDC)

• Centers for Disease Control COVID-19 Broad Agency Announcement (BAA)
• Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health (forecasted)

Office of Assistant Secretary for Preparedness and Response

• Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
• BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement

National Institutes of Health (NIH)

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
• Partnerships for Countermeasures against Select Pathogens
• Emergency Competitive Revision to Existing NIH Awards
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Differs per Institute/Center)
  • Notice of Special Interest (NOSI): Availability of Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
• Investigator Initiated Extended Clinical Trial
• COVID-19 Information for Applicants and Recipients of NIH Funding
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19

• General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19

• NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
• YouTube message to applicants and recipients of NIH funds on flexibilities needed for COVID-19 Public Health Emergency

• Important Notice No. 146 - NSF Letter to Community Regarding COVID-19
• NSF Implementation of OMB Memorandum M-20-17 [PDF]
• Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) [PDF]
  • Existing funding opportunities
  • Rapid Response Research (RAPID)
• Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) [PDF]
• FAQs regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) [PDF]
• Impact on Existing Deadlines [PDF]
• Frequently Asked Questions for NSF Proposers and Awardees [PDF]
• Frequently Asked Questions for NSF Panelists [PDF]
• NSF Guidance for Major Facilities and Contracts Regarding COVID-19 [PDF]
• NSF Supporting Research to Address Coronavirus Disease

• Prototype Development to Combat Novel Coronavirus COVID-19
• DOD Coronavirus Information

• Invitation to COVID-19 Scientific Questions [PDF]
• Accommodating interruptions to applicants and awardees due to COVID-19 [PDF]
• Coronavirus Hub

• Guidance for award recipients
• Deadline Extensions due to COVID-19

• NEH COVID-19 Information

• NEA COVID-19 Information